Atlas Trials

Study of Repeat Intranodal Injection of Memgen's Cancer Vaccine, Ad-ISF35, in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Clinical trial NCT00849524 · TERMINATED

Trial details

NCT number
NCT00849524
Sponsor
Januario Castro, M.D.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Start date
2009-01-01
Primary completion
2009-07-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.